November 3, 2020 -- The U.S. Food and Drug Administration (FDA) has alerted clinical laboratory staff and healthcare providers of the potential for false positive results from antigen tests for rapid detection of SARS-CoV-2.
These false positive findings can occur many reasons, for example when users do not follow instructions for the tests, according to the FDA. The FDA offered several recommendations for clinical laboratory staff and healthcare providers:
When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.Yes, Keep Me Current